PHARMALIS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMALIS
Largest movements
- Cash +€182,483
up €182,483 (+47.5%), from €383,907 to €566,390
mainly Other debts (+€302,234) and Depreciation (+€115,977)
- Current investments -€100,000
no longer reported in 2025 (was €100,000)
- Intangible fixed assets -€81,695
no longer reported in 2025 (was €81,695)
- Stocks and contracts -€28,516
down €28,516 (-14.8%), from €192,909 to €164,393
- Tangible fixed assets -€25,811
down €25,811 (-9.2%), from €281,246 to €255,435
of which Furniture and vehicles: -€15,809
- Reserves -€401,750
down €401,750 (-50.3%), from €798,106 to €396,356
of which Distributable reserves: -€320,055
- Other debts +€302,234
up €302,234 (+66.1%), from €457,041 to €759,276
- Profit (loss) carried forward +€49,967
up €49,967 (+12.9%), from -€388,063 to -€338,096
- Debts after one year -€22,608
down €22,608 (-20.9%), from €108,357 to €85,749
- Depreciation -€81,636
down €81,636 (-41.3%), from €197,613 to €115,977
- Staff costs -€46,857
down €46,857 (-29.0%), from €161,379 to €114,523
- Gross operating margin -€45,968
down €45,968 (-12.0%), from €382,642 to €336,675
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,153,307 | €1,096,463 | -€56,843 | -4.9% |
| Fixed assets | 21/28 | €363,052 | €255,546 | -€107,506 | -29.6% |
| Intangible fixed assets | 21 | €81,695 | - | -€81,695 | |
| Tangible fixed assets | 22/27 | €281,246 | €255,435 | -€25,811 | -9.2% |
| Land and buildings | 22 | €255,895 | €246,354 | -€9,542 | -3.7% |
| Plant, machinery and equipment | 23 | €1,902 | €1,442 | -€460 | -24.2% |
| Furniture and vehicles | 24 | €23,449 | €7,639 | -€15,809 | -67.4% |
| Financial fixed assets | 28 | €111 | €111 | = | 0.0% |
| Current assets | 29/58 | €790,255 | €840,917 | +€50,663 | +6.4% |
| Stocks and contracts in progress | 3 | €192,909 | €164,393 | -€28,516 | -14.8% |
| Stocks | 30/36 | €192,909 | €164,393 | -€28,516 | -14.8% |
| Amounts receivable within one year | 40/41 | €111,607 | €107,592 | -€4,015 | -3.6% |
| Trade receivables | 40 | €66,702 | €79,326 | +€12,625 | +18.9% |
| Other amounts receivable | 41 | €44,906 | €28,266 | -€16,640 | -37.1% |
| Current investments | 50/53 | €100,000 | - | -€100,000 | |
| Cash at bank and in hand | 54/58 | €383,907 | €566,390 | +€182,483 | +47.5% |
| Deferred charges and accrued income | 490/1 | €1,831 | €2,542 | +€711 | +38.8% |
| Total equity and liabilities | 10/49 | €1,153,307 | €1,096,463 | -€56,843 | -4.9% |
| Equity | 10/15 | €437,090 | €85,307 | -€351,783 | -80.5% |
| Contributions | 10/11 | €27,047 | €27,047 | = | 0.0% |
| Reserves | 13 | €798,106 | €396,356 | -€401,750 | -50.3% |
| Tax-exempt reserves | 132 | €81,695 | - | -€81,695 | |
| Distributable reserves | 133 | €716,411 | €396,356 | -€320,055 | -44.7% |
| Profit (loss) carried forward | 14 | -€388,063 | -€338,096 | +€49,967 | +12.9% |
| Amounts payable | 17/49 | €716,217 | €1,011,157 | +€294,940 | +41.2% |
| Amounts payable after more than one year | 17 | €108,357 | €85,749 | -€22,608 | -20.9% |
| Financial debts | 170/4 | €108,357 | €85,749 | -€22,608 | -20.9% |
| Amounts payable within one year | 42/48 | €568,325 | €884,591 | +€316,265 | +55.6% |
| Current portion of amounts payable after more than one year | 42 | €42,099 | €37,609 | -€4,490 | -10.7% |
| Trade debts | 44 | €44,879 | €52,875 | +€7,996 | +17.8% |
| Suppliers | 440/4 | €44,879 | €52,875 | +€7,996 | +17.8% |
| Taxes, remuneration and social security | 45 | €24,306 | €34,831 | +€10,525 | +43.3% |
| Taxes | 450/3 | €4,946 | €8,108 | +€3,163 | +63.9% |
| Remuneration and social security | 454/9 | €19,360 | €26,723 | +€7,363 | +38.0% |
| Other amounts payable | 47/48 | €457,041 | €759,276 | +€302,234 | +66.1% |
| Accrued charges and deferred income | 492/3 | €39,534 | €40,817 | +€1,283 | +3.2% |
| Remuneration, social security and pensions | 62 | €161,379 | €114,523 | -€46,857 | -29.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €197,613 | €115,977 | -€81,636 | -41.3% |
| Other operating charges | 640/8 | €5,406 | €5,948 | +€542 | +10.0% |
| Gross operating margin | 9900 | €382,642 | €336,675 | -€45,968 | -12.0% |
| Operating profit (loss) | 9901 | €18,244 | €100,227 | +€81,983 | +449.4% |
| Financial income | 75/76B | €8,985 | €6,934 | -€2,051 | -22.8% |
| Recurring financial income | 75 | €8,985 | €6,934 | -€2,051 | -22.8% |
| Financial charges | 65/66B | €49,310 | €50,101 | +€792 | +1.6% |
| Recurring financial charges | 65 | €49,310 | €50,101 | +€792 | +1.6% |
| Profit (loss) for the period before taxes | 9903 | -€22,081 | €57,059 | +€79,140 | |
| Income taxes | 67/77 | €39,234 | €38,786 | -€447 | -1.1% |
| Profit (loss) for the period | 9904 | -€61,315 | €18,272 | +€79,587 | |
| Transfer from tax-exempt reserves | 789 | €163,390 | €81,695 | -€81,695 | -50.0% |
| Profit (loss) for the period to be appropriated | 9905 | €102,075 | €99,967 | -€2,108 | -2.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.